Denmark’s Zealand Pharma (CPH: ZEAL), a company focused on the discovery and development of innovative peptide-based ...

UK-based pharma company Indivior (LSE: INDV) saw it shares rose 5.3% to 738.50 pence in early trading today after it ...

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...

A clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies.

Shares in Eli Lilly shot up last Thursday after the US pharma major announced positive top-line Phase III results from ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

A new report highlights disparities in access to CAR T-cell therapies across Europe, with eligible patient treatment rates as ...

Denmark-based allergy immunotherapy specialist ALK Abello (ALKB. DC) today announced that its Itulazax (tree pollen ...

Autoimmune diseases specialist Immunovant has announced changes to its leadership team and the expanded development of its ...

The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...